← SynDRA
BMS-265246
SynDRA canonical compound SYN0052980 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CDK1 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- CDK1 INHIBITOR
- CDK2 INHIBITOR
Cross-references
Synonyms
- BMS265246
- CMPD 21H
- BMS 265246
- GTPL8051
- orb1305177
- SCHEMBL15757461
- SCHEMBL31061024
- CCG-267974
- Sdccgsbi-0654469.P001
- AC-35909
- AS-56200
- SY268759
- RefChem:1080052
- DTXCID80129460
- 4GF4A623RF
- MFCD22420825
- MLS006011031
- BDBM5776
- GLXC-05968
- HMS3655J09
- EX-A2032
- BDBM50503350
- s2014
- AKOS026750598
- CS-0922
- SB19464
- NCGC00346693-01
- NCGC00346693-05
- NCGC00346693-06
- HY-15275
- SMR004702826
- BMS-265246-01
- SW219166-1
- C75728
- BRD-K62814476-001-01-7
- BRD-K62814476-001-03-3
- BRD-K62814476-001-04-1
Look up BMS-265246 in the interactive SynDRA portal →